141 related articles for article (PubMed ID: 18167127)
1. Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
Cancer Sci; 2008 Mar; 99(3):553-63. PubMed ID: 18167127
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
Moro L; Arbini AA; Marra E; Greco M
Int J Oncol; 2007 Jan; 30(1):217-24. PubMed ID: 17143532
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
4. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
[TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
6. Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.
Mainetti LE; Zhe X; Diedrich J; Saliganan AD; Cho WJ; Cher ML; Heath E; Fridman R; Kim HR; Bonfil RD
Int J Cancer; 2015 Jan; 136(1):11-20. PubMed ID: 24798488
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.
Moro L; Arbini AA; Marra E; Greco M
J Biol Chem; 2006 Aug; 281(31):22100-22107. PubMed ID: 16754685
[TBL] [Abstract][Full Text] [Related]
8. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
Moro L; Arbini AA; Marra E; Greco M
J Biol Chem; 2005 Jun; 280(23):22482-91. PubMed ID: 15805113
[TBL] [Abstract][Full Text] [Related]
11. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
[TBL] [Abstract][Full Text] [Related]
12. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
[TBL] [Abstract][Full Text] [Related]
13. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
[TBL] [Abstract][Full Text] [Related]
14. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
15. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
Shin I; Kim S; Song H; Kim HR; Moon A
J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3.
Pal S; Ganguly KK; Chatterjee A
Cell Commun Adhes; 2013 Oct; 20(5):105-14. PubMed ID: 24047237
[TBL] [Abstract][Full Text] [Related]
17. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
18. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
19. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells.
Sroka IC; Nagle RB; Bowden GT
Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]